Per Ladenvall Selected Research

Per Ladenvall Research Topics

19	Stroke (Strokes) 05/2024 - 10/2005
17	Ischemic Stroke 05/2024 - 10/2005
12	Hemorrhage 05/2024 - 04/2017
11	Transient Ischemic Attack 01/2022 - 01/2017
4	Pathologic Constriction (Stenosis) 12/2020 - 01/2017
4	Myocardial Infarction 10/2019 - 01/2002
2	Atrial Fibrillation 05/2024 - 03/2021
2	Cerebral Hemorrhage 05/2024 - 01/2009
2	Atherosclerosis 12/2020 - 01/2017
2	Brain Ischemia (Cerebral Ischemia) 10/2019 - 01/2018
2	Embolic Stroke 01/2017 - 10/2005
1	Rare Diseases (Rare Disease) 05/2024
1	Hematoma 05/2024
1	Neurologic Manifestations (Neurological Manifestations) 05/2024
1	Vascular Diseases (Vascular Disease) 01/2018
1	Patent Foramen Ovale 09/2015
1	Bundle-Branch Block (Fascicular Block) 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2006

14	TicagrelorIBA 01/2023 - 01/2017
14	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 01/2017
2	Factor Xa InhibitorsIBA 05/2024 - 05/2024
2	PRT064445IBA 05/2024 - 05/2024
2	Hemostatics (Antihemorrhagics)IBA 05/2024 - 05/2024
2	C-Reactive ProteinIBA 01/2009 - 08/2006
2	danaparoid (Orgaran)FDA Link 01/2009 - 10/2005
1	eculizumab FDA Link 05/2024
1	AnticoagulantsIBA 03/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 03/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	CholesterolIBA 01/2021
1	Clopidogrel (Plavix)FDA Link 01/2020
1	Gap Junction alpha-5 ProteinIBA 01/2015
1	Connexin 43 (Connexin43)IBA 01/2015
1	ORALIT (ORS)IBA 08/2006
1	Blood Proteins (Serum Proteins)IBA 10/2005
1	AntigensIBA 10/2005
1	Tissue Polypeptide AntigenIBA 10/2005
1	Plasminogen Activator Inhibitor 1IBA 10/2005
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2002

7	Therapeutics 05/2024 - 09/2015
1	Thrombectomy 01/2020